| Schedule of basic and diluted income per share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30, |
|
Six Months Ended June 30, |
|
|
2025 |
|
2024 |
|
2025 |
|
2024 |
Net income (in thousands) |
|
$ |
151,602 |
|
$ |
150,723 |
|
$ |
274,986 |
|
$ |
303,104 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average number of common shares outstanding - basic |
|
|
28,371,644 |
|
|
31,324,833 |
|
|
28,698,125 |
|
|
31,483,144 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Dilutive effect of common stock equivalents: |
|
|
|
|
|
|
|
|
|
|
|
|
RSAs with service-based conditions |
|
|
12,893 |
|
|
34,973 |
|
|
21,949 |
|
|
38,083 |
RSAs with market-based conditions |
|
|
32,363 |
|
|
61,856 |
|
|
31,218 |
|
|
61,491 |
RSAs with performance-based conditions |
|
|
17,918 |
|
|
10,885 |
|
|
25,500 |
|
|
17,474 |
Stock options |
|
|
80,736 |
|
|
91,516 |
|
|
81,927 |
|
|
93,332 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average number of common shares outstanding - diluted |
|
|
28,515,554 |
|
|
31,524,063 |
|
|
28,858,719 |
|
|
31,693,524 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic net income per common share |
|
$ |
5.34 |
|
$ |
4.81 |
|
$ |
9.58 |
|
$ |
9.63 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted net income per common share |
|
$ |
5.32 |
|
$ |
4.78 |
|
$ |
9.53 |
|
$ |
9.56 |
|
| Summary of shares excluded from the calculation of diluted income per share because their effect would have been anti-dilutive |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30, |
|
Six Months Ended June 30, |
|
|
2025 |
|
2024 |
|
2025 |
|
2024 |
Anti-dilutive common stock equivalents: |
|
|
|
|
|
|
|
|
|
|
|
|
RSAs with service-based conditions |
|
|
9,980 |
|
|
— |
|
|
10,053 |
|
|
— |
RSAs with market-based conditions |
|
|
24,852 |
|
|
— |
|
|
21,101 |
|
|
— |
RSAs with performance-based conditions |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
Stock options |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
Total anti-dilutive common stock equivalents |
|
|
34,832 |
|
|
— |
|
|
31,154 |
|
|
— |
|